The importance of vaccination and immunoglobulin treatment for patients with primary immunodeficiency diseases (PIDs) ‐ World PI Week April 22–29, 2015

Publisher： John Wiley & Sons Inc

E-ISSN： 1521-4141|45|5|1285-1286

ISSN： 0014-2980

Source： EUROPEAN JOURNAL OF IMMUNOLOGY, Vol.45, Iss.5, 2015-05, pp. : 1285-1286

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Current treatment options with immunoglobulin G for the individualization of care in patients with primary immunodeficiency disease

By  

CLINICAL & EXPERIMENTAL IMMUNOLOGY, Vol. 179, Iss. 2, 2015-02 ,pp. : 146-160

John Wiley & Sons Inc

Access to resources Recommend Favorite

Population Pharmacokinetics of Intravenous Busulfan in Japanese Pediatric Patients With Primary Immunodeficiency Diseases

By  

JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 58, Iss. 3, 2018-03 ,pp. : 327-331

John Wiley & Sons Inc

Access to resources Recommend Favorite

An open, prospective trial investigating the pharmacokinetics and safety, and the tolerability of escalating infusion rates of a 10% human normal immunoglobulin for intravenous infusion (IVIg), BT090, in patients with primary immunodeficiency disease

By  

VOX SANGUINIS, Vol. 109, Iss. 3, 2015-10 ,pp. : 248-256

John Wiley & Sons Inc

Access to resources Recommend Favorite

Immunoglobulin Replacement Therapy in Primary Antibody Deficiency Diseases – Maximizing Success

By  

International Archives of Allergy and Immunology, Vol. 136, Iss. 3, 2005-03 ,pp. : 217-229

Karger

Access to resources Recommend Favorite

Hemolysis in patients with antibody deficiencies on immunoglobulin replacement treatment

By  

TRANSFUSION, Vol. 55, Iss. 5, 2015-05 ,pp. : 1067-1074

John Wiley & Sons Inc

Access to resources Recommend Favorite